Integra Lifesciences Holdings Corp (STU:IL3)
€ 23.8 0.8 (3.48%) Market Cap: 1.83 Bil Enterprise Value: 3.43 Bil PE Ratio: 0 PB Ratio: 1.29 GF Score: 71/100

Q4 2019 Integra Lifesciences Holdings Corp Earnings Call Transcript

Feb 19, 2020 / 01:30PM GMT
Release Date Price: €56 (+3.70%)
Operator

Good day, and welcome to the Integra LifeSciences Fourth Quarter and Full Year 2019 Financial Results Conference Call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mike Beaulieu, Director of Investor Relations. Sir, please go ahead.

Michael Beaulieu
Integra LifeSciences Holdings Corporation - Director of IR

Thank you, Katie. Good morning, and thank you for joining the Integra LifeSciences Fourth Quarter and Full Year 2019 Earnings Conference Call. Joining me on the call are Peter Arduini, President and Chief Executive Officer; Glenn Coleman, Chief Operating Officer; Carrie Anderson, Chief Financial Officer; and Sravan Emany, Senior Vice President, Strategy, Treasury and Investor Relations.

Earlier this morning, we issued a press release announcing our fourth quarter and full year 2019 financial results. The release and corresponding earnings presentation, which we will reference during the call, are available at integralife.com under Investors, Events and Presentations in the file named Fourth Quarter

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot